Quantitative measurement of peritumoral concentrations of glutamate, N-acetyl aspartate, and lactate on magnetic resonance spectroscopy predicts glioblastoma-related refractory epilepsy
Quantitative measurement of peritumoral concentrations of glutamate, N-acetyl aspartate, and lactate on magnetic resonance spectroscopy predicts glioblastoma-related refractory epilepsy
复制标题
磁共振波谱定量测量瘤周谷氨酸、N-乙酰天冬氨酸和乳酸浓度可预测胶质母细胞瘤相关的难治性癫痫
DOI:
10.1007/s00701-022-05363-y
复制
发表时间:
2022
影响因子:
2.4
通讯作者:
Kunieda Takeharu
中科院分区:
文献类型:
--
作者:
Nakamura Yawara;Inoue Akihiro;Nishikawa Masahiro;Ohnishi Takanori;Yano Hajime;Kanemura Yonehiro;Ohtsuka Yoshihiro;Ozaki Saya;Kusakabe Kosuke;Suehiro Satoshi;Yamashita Daisuke;Shigekawa Seiji;Watanabe Hideaki;Kitazawa Riko;Tanaka Junya;Kunieda Takeharu
BackgroundIncreased extracellular glutamate is known to cause epileptic seizures in patients with glioblastoma (GBM). However, predicting whether the seizure will be refractory is difficult. The present study investigated whether evaluation of the levels of various metabolites, including glutamate, can predict the occurrence of refractory seizure in GBM by quantitative measurement of metabolite concentrations on magnetic resonance spectroscopy (MRS).MethodsForty patients were treated according to the same treatment protocol for primary GBM at Ehime University Hospital between April 2017 and July 2021. Of these patients, 23 underwent MRS to determine concentrations of metabolites, including glutamate, N-acetylaspartate, creatine, and lactate, in the tumor periphery by applying LC-Model. The concentration of each metabolite was expressed as a ratio to creatine concentration. Patients were divided into three groups: Type A, patients with no seizures; Type B, patients with seizures that disappeared after treatment; and Type C, patients with seizures that remained unrelieved or appeared after treatment (refractory seizures). Relationships between concentrations of metabolites and seizure types were investigated.ResultsIn 23 GBMs, seizures were confirmed in 11 patients, including Type B in four and Type C in seven. Patients with epilepsy (Type B or C) showed significantly higher glutamate and N-acetylaspartate values than did non-epilepsy patients (Type A) (p < 0.05). No significant differences in glutamate or N-acetylaspartate levels were seen between Types B and C. Conversely, Type C showed significantly higher concentrations of lactate than did Type B (p = 0.001). Cutoff values of lactate-to-creatine, glutamate-to-creatine, and N-acetylaspartate-to-creatine ratios for refractory seizure were > 1.25, > 1.09, and > 0.88, respectively.ConclusionsExtracellular concentrations of glutamate, N-acetylaspartate, and lactate in the tumor periphery were significantly elevated in patients with GBM with refractory seizures. Measurement of these metabolites on MRS may predict refractory epilepsy in such patients and could be an indicator for continuing the use of antiepileptic drugs.
登录
查看更多内容
影响因子:
158.5
作者:
Stupp, R;Mason, WP;Ryan, G
通讯作者:
Ryan, G
影响因子:
4.3
作者:
Dey S;Doddamani RS;Banerjee Dixit A;Tripathi M;Sharma MC;Chandra PS;Banerjee J
通讯作者:
Banerjee J
影响因子:
15.9
作者:
Schiff, David;Lee, Eudocia Q.;Wen, Patrick Y.
通讯作者:
Wen, Patrick Y.
DOI:
10.1006/jmra.1994.1008
发表时间:
1994-01-01
期刊:
JOURNAL OF MAGNETIC RESONANCE SERIES A
影响因子:
--
作者:
SMITH, SA;LEVANTE, TO;ERNST, RR
通讯作者:
ERNST, RR
影响因子:
0.6
作者:
Roesche, J.;Piek, J.;Benecke, R.
通讯作者:
Benecke, R.